Interestingly, in different BRCA subtypes, the correlations between DIP2B expression and immune score, infiltration of key immune killer cells, and the expression of MHC-related genes and chemokine-related genes showed a consistent tendency. Here, DIP2B is linked to invasive breast carcinoma.